EBS
- Emergent BioSolutions Inc.
()
Overview
Company Summary
Emergent BioSolutions Inc. (EBS) is a global specialty biopharmaceutical company that focuses on the development, manufacture, and distribution of vaccines, therapeutics, and devices for various public health threats.
The company is primarily involved in providing solutions for infectious diseases, whether naturally occurring or intentionally spread biological threats, as well as related areas such as oncology, autoimmune disorders, and chronic liver diseases. EBS works towards safeguarding and enhancing global health security by developing innovative products to prevent, treat, and manage these conditions effectively.
EBS operates across three main business units:
1. Biodefense: This unit encompasses the development, production, and supply of medical countermeasures (MCMs) for defense against bioterrorism and naturally occurring infectious diseases. Emergent BioSolutions is a key supplier to various governments and organizations worldwide, supporting preparedness and response efforts for pathogens like anthrax, smallpox, botulism, and more.
2. Public Health: EBS has a portfolio of vaccines and therapeutics designed to meet public health needs. This includes combating diseases like typhoid fever, cholera, travel-related conditions, and respiratory syncytial virus (RSV) infection. These products focus on preventing and treating diseases that impact populations globally, particularly those with limited access to healthcare resources.
3. Contract Development and Manufacturing: EBS provides contract development and manufacturing services for a range of customers, including government agencies, biotechnology companies, and global pharmaceutical corporations. This involves offering expertise in process development, technology transfer, and large-scale production of biopharmaceuticals.
Overall, Emergent BioSolutions Inc. plays a crucial role in the biopharmaceutical industry by addressing public health threats through the development, production, and distribution of vaccines, therapeutics, and devices, both for governmental customers and public health organizations worldwide.